Related Experiment Video
Updated: Mar 8, 2026
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
[Second Korean Guidelines for the Management of Crohn's Disease]
Jae Jun Park1, Suk Kyun Yang2, Byong Duk Ye2
1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Insights
Updated Korean guidelines offer evidence-based approaches for managing Crohn's disease (CD), an inflammatory bowel disease (IBD). These revised recommendations address treatment variations and complications to improve patient care.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Practice Guidelines
Background:
- Crohn's disease (CD) is a chronic, disabling inflammatory bowel disease (IBD) with increasing incidence in Korea.
- CD affects the entire gastrointestinal tract and can lead to severe complications like strictures and fistulas.
- Current CD management shows significant variability among clinicians, necessitating standardized recommendations.
Purpose of the Study:
- To present revised, evidence-based guidelines for Crohn's disease management in Korea.
- To provide standardized recommendations for induction and maintenance therapy, disease location-specific treatment, and complication management.
- To minimize treatment discrepancies and improve patient outcomes for inflammatory bowel disease.
Main Methods:
- Development of revised guidelines using primarily adaptation methods based on updated evidence.
- Systematic review and synthesis of recent research since the 2012 guidelines.
- Inclusion of treatment strategies for CD complications, surgical management, and post-operative recurrence prevention.
Main Results:
- The guidelines encompass comprehensive management strategies for Crohn's disease.
- Recommendations cover induction and maintenance treatments, tailored approaches for different disease locations, and management of complications such as strictures and fistulas.
- The guidelines also address surgical treatment and strategies for preventing recurrence after surgery.
Conclusions:
- These revised Korean guidelines provide a framework for consistent and improved management of Crohn's disease.
- The guidelines aim to reduce clinical practice variations and enhance the care of patients with inflammatory bowel disease.
- Continuous revision based on accumulating evidence ensures the guidelines remain current and relevant.
Abstract:
Crohn's disease (CD) is a chronic, progressive, and disabling inflammatory bowel disease (IBD) with an uncertain etiopathogenesis. CD can involve any site of the gastrointestinal tract from the mouth to the anus, and is associated with serious complications, such as bowel strictures, perforations, and fistula formation. The incidence and prevalence rates of CD in Korea are still lower compared with those in Western countries, but they have been rapidly increasing during the recent decades. Although there are no definitive curative modalities for CD, various medical and surgical therapies have been applied for the treatment of this disease. Concerning CD management, there have been substantial discrepancies among clinicians according to their personal experience and preference. To suggest recommendable approaches to the diverse problems of CD and to minimize the variations in treatment among physicians, guidelines for the management of CD were first published in 2012 by the IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. These are the revised guidelines based on updated evidence, accumulated since 2012. These guidelines were developed by using mainly adaptation methods, and encompass induction and maintenance treatment of CD, treatment based on disease location, treatment of CD complications, including stricture and fistula, surgical treatment, and prevention of postoperative recurrence. These are the second Korean guidelines for the management of CD and will be continuously revised as new evidence is collected.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...